1. Progressive multifocal leukoencephalopathy in an immunocompetent patient: A case report and review of literature
- Author
-
Arshdeep Kaur, Erum Khan, Syed Hassan Khalid, Parissa Feizi, and Shitiz Sriwastava
- Subjects
Male ,medicine.medical_specialty ,Pediatrics ,medicine.medical_treatment ,JC virus ,Mirtazapine ,medicine.disease_cause ,Virology ,Aphasia ,medicine ,Humans ,Hemianopsia ,business.industry ,Mortality rate ,Progressive multifocal leukoencephalopathy ,Leukoencephalopathy, Progressive Multifocal ,Brain ,Immunosuppression ,Middle Aged ,medicine.disease ,JC Virus ,Magnetic Resonance Imaging ,Infectious Diseases ,Hemiparesis ,Histopathology ,medicine.symptom ,business - Abstract
BACKGROUND Progressive multifocal leukoencephalopathy, (PML) a demyelinating disease of the brain, caused by the John Cunningham (JC Virus) is usually seen in patients who are immunocompromised. Here, we describe a case of an immunocompetent patient diagnosed with PML and a comprehensive literature review. CASE DESCRIPTION A 64-year-old Caucasian male presented with acute worsening of progressive neurological decline with difficulty in vision and reading. Based on history, examination, CSF markers, histopathology, and MRI Brain at the time of presentation diagnosed the patient with PML in a setting of no immunosuppression disorder. Patient was started on Pelfilgrastim with significant systematic improvement. RESULT In our literature review, it was seen that the average age of symptom presentation was 57.5 with predominance in males. Most of the patients presented with progressive neurological deficits with symptomology ranging from mild confusion, aphasia, anxiety to sensory disturbances with numbness, hemiparesis and hemianopsia. Out of the 21 cases, patients responded to mirtazapine and intravenous pulse methylprednisolone (IVMP). The mortality rate was close to 50% with 11 fatal cases and 10 non-fatal cases. CONCLUSION Our case and literature review demonstrate the possibility that PML may very rarely occur in patients that our immunocompetent. Furthermore, our review showed that patients responded well to mirtazapine and IVMP. We also want to highlight that mortality rate was lower in this review and was only compared to morality in PML associated with immunocompromised status. This article is protected by copyright. All rights reserved.
- Published
- 2021